|
Market Closed -
Nasdaq
01:00:01 21/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.000 USD | -8.05% |
|
+3.09% | +40.85% |
Company Valuation: Edesa Biotech, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 97.83 | 14.25 | 13.33 | 14.45 | 17.38 | 27.02 | - | - |
| Change | - | -85.44% | -6.42% | 8.4% | 20.29% | 55.46% | - | - |
| Enterprise Value (EV) | 97.83 | 14.25 | 13.33 | 14.45 | 17.38 | 27.02 | 27.02 | 27.02 |
| Change | - | -85.44% | -6.42% | 8.4% | 20.29% | 55.46% | 0% | 0% |
| P/E | -6.71x | -0.88x | -1.51x | -2.31x | -1.94x | -1.01x | -0.97x | -0.98x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.19x | 0x | 0.1x | 0.1x | -0x | -0.24x | 1.21x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 1.16x |
| EV / Revenue | - | - | - | - | - | - | - | 1.16x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -1.51x | -1.12x | -0.82x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -7.7 | -7.35 | -2.93 | -1.93 | -1.27 | -1.987 | -2.067 | -2.05 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 23.26 |
| EBITDA | -23.56 | - | - | - | - | - | - | - |
| EBIT 1 | -23.68 | -18.37 | -9.223 | -7.015 | -7.912 | -17.93 | -24.13 | -32.89 |
| Net income 1 | -13.34 | -17.55 | -8.374 | -6.17 | -7.186 | -17.52 | -23.88 | -32.64 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 51.660 | 6.449 | 4.424 | 4.450 | 2.470 | 2.000 | 2.000 | 2.000 |
| Nbr of stocks (in thousands) | 1,894 | 2,209 | 3,013 | 3,247 | 7,038 | 13,512 | - | - |
| Announcement Date | 29/12/21 | 16/12/22 | 16/12/23 | 14/12/24 | 13/12/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.09x | - | - | - | 27.02M | ||
| 17.12x | 6.54x | 12.53x | 1.74% | 63.66B | ||
| 31.85x | 8.5x | 28.11x | 0.07% | 58.56B | ||
| 38.62x | 6.88x | 20.55x | 0.84% | 54.19B | ||
| 41.79x | 5.95x | 28.33x | -.--% | 44.66B | ||
| 32.7x | 3.15x | 13.61x | -.--% | 40.51B | ||
| 36.32x | 8.98x | 23.42x | 0.36% | 36.27B | ||
| -18.89x | 54.48x | -20.65x | -.--% | 34.89B | ||
| 41.53x | 8.01x | 26.87x | -.--% | 32.26B | ||
| -89.49x | 16.75x | -96.22x | -.--% | 31.01B | ||
| Average | 13.05x | 13.25x | 4.06x | 0.33% | 40B | |
| Weighted average by Cap. | 18.84x | 11.83x | 8.55x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EDSA Stock
- Valuation Edesa Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
















